Raynaud's phenomenon in mixed connective tissue disease

Rheumatic Disease Clinics of North America

Volumn 31, Issue 3, 2005, Pages 465-481

  Grader Beck, Thomas ^a   Wigley, Fredrick M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGININE; AUTOANTIBODY; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; FELODIPINE; FLUOXETINE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILOPROST; ISRADIPINE; NIFEDIPINE; NITRATE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; PROSTACYCLIN; PROSTAGLANDIN E1; RIBONUCLEOPROTEIN ANTIBODY; SEROTONIN UPTAKE INHIBITOR;

CAPILLARY; CELL INFILTRATION; CLINICAL TRIAL; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HEAT; HUMAN; ISCHEMIA; MIXED CONNECTIVE TISSUE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; RISK ASSESSMENT; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPERATURE; VASCULAR DISEASE;

AUTOANTIBODIES; CAPILLARIES; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; NAILS; RAYNAUD DISEASE; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 23444442524     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.04.006     Document Type: Review

References (93)

1. G.C. Sharp, W.S. Irvin, and E.M. Tan Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Am J Med 52 2 1972 148 159
2. M.A. Burdt, R.W. Hoffman, and S.L. Deutscher Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings Arthritis Rheum 42 5 1999 899 909
3. J. Calderon, V. Rodriguez-Valverde, and S. Sanchez Andrade Clinical profiles of patients with antibodies to nuclear ribonucleoprotein Clin Rheumatol 3 4 1984 483 492
4. F. Granier, M. Vayssairat, and P. Priollet Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus Arthritis Rheum 29 2 1986 189 195
5. R.M. Bennett, and D.J. O'Connell Mixed connective tissue disease: a clinicopathologic study of 20 cases Semin Arthritis Rheum 10 1 1980 25 51
6. J. Jonsson, and R. Norberg Symptomatology and diagnosis in connective tissue disease. II. Evaluations and follow-up examinations in consequence of a speckled antinuclear immunofluorescence pattern Scand J Rheumatol 7 4 1978 229 236
7. D. Alarcon-Segovia, and M. Villareal Classification and diagnostic criteria for mixed connective tissue disease R. Kasukawa G.C. Sharp Mixed connective tissue disease and anti-nuclear antibodies 1987 Elsevier Amsterdam 33 40
8. A.C. Gelber, F.M. Wigley, and R.Y. Stallings Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity J Clin Epidemiol 52 5 1999 441 446
9. J.A. Block, and W. Sequeira Raynaud's phenomenon Lancet 357 9273 2001 2042 2048
10. H.R. Maricq, P.H. Carpentier, and M.C. Weinrich Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France J Rheumatol 20 1 1993 70 76
11. D. Estes, and C.L. Christian The natural history of systemic lupus erythematosus by prospective analysis Medicine (Baltimore) 50 2 1971 85 95
12. M.C. Hochberg, R.E. Boyd, and J.M. Ahearn Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets Medicine (Baltimore) 64 5 1985 285 295
13. M. Garcia-Carrasco, A. Siso, and M. Ramos-Casals Raynaud's phenomenon in primary Sjogren's syndrome. Prevalence and clinical characteristics in a series of 320 patients J Rheumatol 29 4 2002 726 730
14. A. Saraux, J. Allain, and C. Guedes Raynaud's phenomenon in rheumatoid arthritis Br J Rheumatol 35 8 1996 752 754
15. R. De Angelis, A. Cerioni, and P. Del Medico Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD) Clin Rheumatol 24 2 2005 145 151
16. M. Mosca, R. Neri, and W. Bencivelli Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years J Rheumatol 29 11 2002 2345 2349
17. G.C. Sharp, W.S. Irvin, and C.M. May Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases N Engl J Med 295 21 1976 1149 1154
18. D.L. Tuffanelli, and R.K. Winkelmann Systemic scleroderma, A clinical study of 727 cases Arch Dermatol 84 1961 359 371
19. M.D. Parker Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease J Lab Clin Med 82 5 1973 769 775
20. M.L. Cohen, B. Dawkins, and R.L. Dawkins Clinical significance of antibodies to ribonucleoprotein Ann Rheum Dis 38 1 1979 74 78
21. R. Kasukawa, T. Tojo, and S. Miyawaki Preliminary diagnostic criteria for classification of mixed connective tissue disease R. Kasukawa G.C. Sharp Mixed connective tissue disease and anti-nuclear antibodies 1987 Elsevier Amsterdam 41 47
22. G.C. Sharp Diagnostic criteria for classification of mixed connective tissue disease R. Kasukawa G.C. Sharp Mixed connective tissue disease and anti-nuclear antibodies 1987 Elsevier Amsterdam 23 32
23. M.F. Kahn, and T. Appelboom Syndrome de Sharp M.F. Kahn A.P. Peltier O. Meyer Les Maladies Systemiques 1991 Flammarion Paris 545 552
24. P.M. Houtman, C.G. Kallenberg, and V. Fidler Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease J Rheumatol 13 3 1986 556 563
25. P. Zufferey, M. Depairon, and A.M. Chamot Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study Clin Rheumatol 11 4 1992 536 541
26. G. Monticone, L. Colonna, and G. Palermi Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects J Am Acad Dermatol 42 5 Pt 1 2000 787 790
27. H.R. Maricq Wide-field capillary microscopy Arthritis Rheum 24 9 1981 1159 1165
28. D. Blockmans, J. Vermylen, and H. Bobbaers Nailfold capillaroscopy in connective tissue disorders and in Raynaud's phenomenon Acta Clin Belg 48 1 1993 30 41
29. H.R. Maricq, E.C. LeRoy, and W.A. D'Angelo Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis Rheum 23 2 1980 183 189
30. R.N. Furtado, M.L. Pucinelli, and V.V. Cristo Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients Lupus 11 1 2002 35 41
31. F. Lefford, and J.C. Edwards Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis Ann Rheum Dis 45 9 1986 741 749
32. R. Hesselstrand, A. Scheja, and G.Q. Shen The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis Rheumatology (Oxford) 42 4 2003 534 540
33. M. Mattioli, and M. Reichlin Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera J Immunol 107 5 1971 1281 1290
34. M. Reichlin, and M. Mattioli Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus N Engl J Med 286 17 1972 908 911
35. M. Mosca, A. Tavoni, and R. Neri Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year Lupus 7 2 1998 95 100
36. M.G. Danieli, P. Fraticelli, and F. Franceschini Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases Clin Exp Rheumatol 17 5 1999 585 591
37. H. Ihn, K. Yamane, and N. Yazawa Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis Clin Exp Immunol 117 2 1999 383 387
38. M. Kuwana, J. Kaburaki, and Y. Okano Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis Arthritis Rheum 37 1 1994 75 83
39. I.E. Hoffman, I. Peene, and L. Meheus Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus Ann Rheum Dis 63 9 2004 1155 1158
40. E.J. ter Borg, H. Groen, and G. Horst Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus Semin Arthritis Rheum 20 3 1990 164 173
41. M. Nakano, H. Hasegawa, and T. Takada Pulmonary diffusion capacity in patients with systemic lupus erythematosus Respirology 7 1 2002 45 49
42. I. Pettersson, M. Hinterberger, and T. Mimori The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies J Biol Chem 259 9 1984 5907 5914
43. I. Pettersson, G. Wang, and E.I. Smith The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study Arthritis Rheum 29 8 1986 986 996
44. W.J. Habets, D.J. de Rooij, and M.H. Salden Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease Clin Exp Immunol 54 1 1983 265 276
45. F.M. Wigley, R.A. Wise, and R. Miller Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis Arthritis Rheum 35 6 1992 688 693
46. L. Schachna, F.M. Wigley, and S. Morris Recognition of granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss Arthritis Rheum 46 7 2002 1873 1884
47. N.A. Flavahan, S. Flavahan, and Q. Liu Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma Arthritis Rheum 43 8 2000 1886 1890
48. M. Udvardy, E. Bodolay, and G. Szegedi Alterations of primary haemostasis in mixed connective tissue disease (MCTD) Thromb Res 63 3 1991 281 286
49. T. Sawai, K. Tutikawa, and T. Watanabe [A case of mixed connective tissue disease (MCTD) complicating pulmonary hypertension and portal hypertension] Ryumachi 28 3 1988 164 169 [in Japanese]
50. M. Pallis, N. Hopkinson, and J. Lowe An electron microscopic study of muscle capillary wall thickening in systemic lupus erythematosus Lupus 3 5 1994 401 407
51. A. von Bierbrauer, P. Barth, and J. Willert Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels Br J Rheumatol 37 12 1998 1272 1278
52. C.M. Magro, A.N. Crowson, and S. Regauer Mixed connective tissue disease. A clinical, histologic, and immunofluorescence study of eight cases Am J Dermatopathol 19 3 1997 206 213
53. B.H. Singsen, V.L. Swanson, and B.H. Bernstein A histologic evaluation of mixed connective tissue disease in childhood Am J Med 68 5 1980 710 717
54. W.D. Sullivan, D.J. Hurst, and C.E. Harmon A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease Medicine (Baltimore) 63 2 1984 92 107
55. J. Braun, J. Sieper, and A. Schwarz Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature Rheumatol Int 13 1 1993 31 36
56. T. Yamaguchi, S. Ohshima, and T. Tanaka Renal crisis due to intimal hyperplasia in a patient with mixed connective tissue disease (MCTD) accompanied by pulmonary hypertension Intern Med 40 12 2001 1250 1253
57. D.J. de Rooij, W.J. Habets, and L.B. van de Putte Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients Ann Rheum Dis 49 6 1990 391 395
58. M.H. Taylor, J.A. McFadden, and M.B. Bolster Ulnar artery involvement in systemic sclerosis (scleroderma) J Rheumatol 29 1 2002 102 106
59. R. Sgonc, M.S. Gruschwitz, and G. Boeck Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95 Arthritis Rheum 43 11 2000 2550 2562
60. E. Bodolay, F. Bojan, and G. Szegedi Cytotoxic endothelial cell antibodies in mixed connective tissue disease Immunol Lett 20 2 1989 163 167
61. E. Bodolay, I. Csipo, and I. Gal Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms Clin Exp Rheumatol 22 4 2004 409 415
62. M. Okawa-Takatsuji, S. Aotsuka, and S. Uwatoko Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases Clin Exp Immunol 126 2 2001 345 354
63. M. Okawa-Takatsuji, S. Aotsuka, and S. Uwatoko Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein Clin Exp Rheumatol 17 6 1999 705 712
64. M. Okawa-Takatsuji, S. Aotsuka, and M. Fujinami Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein Clin Exp Immunol 116 1 1999 174 180
65. M. Okawa-Takatsuji, S. Aotsuka, and S. Uwatoko Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD) Clin Exp Immunol 98 3 1994 427 433
66. E. Weber, A. Rossi, and R. Solito Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture Microvasc Res 64 1 2002 47 55
67. F.K. Tan, F.C. Arnett, and S. Antohi Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases J Immunol 163 2 1999 1066 1072
68. I. Lundberg, S. Antohi, and K. Takeuki Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome J Autoimmun 14 3 2000 267 274
69. A.E. Thompson, B. Shea, and V. Welch Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis Arthritis Rheum 44 8 2001 1841 1847
70. C.G. Kallenberg, A.A. Wouda, and L. Meems Once daily felodipine in patients with primary Raynaud's phenomenon Eur J Clin Pharmacol 40 3 1991 313 315
71. J.F. Schmidt, N. Valentin, and S.L. Nielsen The clinical effect of felodipine and nifedipine in Raynaud's phenomenon Eur J Clin Pharmacol 37 2 1989 191 192
72. F.M. Wigley, J.R. Seibold, and R.A. Wise Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis J Rheumatol 19 9 1992 1407 1414
73. M. Rademaker, E.D. Cooke, and N.E. Almond Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study BMJ 298 6673 1989 561 564
74. R. Scorza, M. Caronni, and B. Mascagni Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study Clin Exp Rheumatol 19 5 2001 503 508
75. F.M. Wigley, J.H. Korn, and M.E. Csuka Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study Arthritis Rheum 41 4 1998 670 677
76. C.M. Black, J.H. Korn, and M.D. Mayes Improvements in the net ulcer burden and hand functionality in patients with digital ulcers related to systemic sclerosis Arthritis Rheum 48 Suppl 2003 S454 S455
77. M. Humbert, and J. Cabane Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan Rheumatology (Oxford) 42 1 2003 191 193
78. J.H. Korn, M. Mayes, and M. Matucci Cerinic Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist Arthritis Rheum 50 12 2004 3985 3993
79. M. Ramos-Casals, P. Brito-Zeron, and N. Nardi Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis Rheumatology (Oxford) 43 11 2004 1454 1456
80. B. Coleiro, S.E. Marshall, and C.P. Denton Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine Rheumatology (Oxford) 40 9 2001 1038 1043
81. J. Goldberg, and A. Dlesk Successful treatment of Raynaud's phenomenon with pentoxifylline Arthritis Rheum 29 8 1986 1055 1056
82. S.M. Dean, and B. Satiani Three cases of digital ischemia successfully treated with cilostazol Vasc Med 6 4 2001 245 248
83. S. Rajagopalan, D. Pfenninger, and E. Somers Effects of cilostazol in patients with Raynaud's syndrome Am J Cardiol 92 11 2003 1310 1315
84. C.M. White Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation J Clin Pharmacol 39 2 1999 111 118
85. J. van der Meer, A.A. Wouda, and C.G. Kallenberg A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon Vasa Suppl 18 1987 71 75
86. V.L. Beckett, D.L. Conn, and V. Fuster Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin Arthritis Rheum 27 10 1984 1137 1143
87. C.P. Denton, K. Howell, and R.J. Stratton Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study Clin Exp Rheumatol 18 4 2000 499 502
88. R.C. Lowell, P. Gloviczki, and K.J. Cherry Jr Cervicothoracic sympathectomy for Raynaud's syndrome Int Angiol 12 2 1993 168 172
89. R.D. Sayers, R.E. Jenner, and W.W. Barrie Transthoracic endoscopic sympathectomy for hyperhidrosis and Raynaud's phenomenon Eur J Vasc Surg 8 5 1994 627 631
90. R.W. Gifford Jr, E.A. Hines Jr, and W.M. Craig Sympathectomy for Raynaud's phenomenon; follow-up study of 70 women with Raynaud's disease and 54 women with secondary Raynaud's phenomenon Circulation 17 1 1958 5 13
91. W. Montorsi, C. Ghiringhelli, and F. Annoni Indications and results of the surgical treatment in Raynaud's phenomenon J Cardiovasc Surg (Torino) 21 2 1980 203 210
92. M.M. Tomaino, R.J. Goitz, and T.A. Medsger Surgery for ischemic pain and Raynaud's' phenomenon in scleroderma: a description of treatment protocol and evaluation of results Microsurgery 21 3 2001 75 79
93. L.K. Hummers, and F.M. Wigley Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma Rheum Dis Clin North Am 29 2 2003 293 313